February 02, 2026 a 04:38 pm
SYK: Analysts Ratings - Stryker Corporation
The Stryker Corporation (SYK) has maintained a stable position in the medical technology sector, experiencing generally positive sentiment from analysts. Recently, there has been a slight shift towards more conservative ratings, indicating a cautious market outlook despite the company's solid performance. Overall, Stryker remains a strong player in its industry, but analysts suggest more scrutiny is needed regarding future growth potential.
Historical Stock Grades
| Rating Type | Number of Ratings | Score |
|---|---|---|
| Strong Buy | 9 | |
| Buy | 13 | |
| Hold | 8 | |
| Sell | 0 | |
| Strong Sell | 1 |
Sentiment Development
Over recent months, the number of 'Strong Buy' ratings has shown small fluctuations while maintaining an overall positive outlook, whereas 'Hold' ratings have seen a slight increase. This shift suggests analysts may be becoming more cautious. Key observations include:
- A steady 'Buy' rating number, indicating continued confidence.
- No 'Sell' recommendations, emphasizing fundamental strength.
- An emerging pattern of cautious optimism among analysts.
Percentage Trends
The distribution of ratings over the past months illustrates a swing towards more conservative holdings:
- 'Strong Buy' ratings decreased slightly from earlier highs.
- A discernible increase in 'Hold' positions, reflecting a more cautious approach.
- Overall rating sentiment remains predominantly positive, with minimal bearish indications.
- The noticeable trend towards 'Hold' indicates a growing watchfulness.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-30 | Buy | Buy | Needham |
| 2026-01-30 | Buy | Buy | BTIG |
| 2026-01-09 | Outperform | Outperform | Bernstein |
| 2025-12-19 | Market Outperform | Market Perform | Citizens |
| 2025-12-18 | Hold | Hold | Truist Securities |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-12-19 | Market Outperform | Market Perform | Citizens |
| 2024-12-02 | Overweight | Equal Weight | Morgan Stanley |
| 2024-05-22 | Buy | Hold | Needham |
| 2024-01-31 | Buy | Hold | Canaccord Genuity |
| 2023-09-05 | Buy | Neutral | B of A Securities |
Interpretation
The consistent 'Buy' and 'Strong Buy' ratings suggest sustained confidence in Stryker's performance, though the increase in 'Hold' ratings may indicate caution due to market conditions or internal factors. The few upgrades reflect shifts in strategic outlooks by major firms, enhancing the understanding of Stryker's market position. However, a stable 'Sell' figure denotes little perceived risk, maintaining overall investor confidence.
Conclusion
Stryker Corporation's analyst ratings remain largely positive, reflected by stable 'Buy' recommendations and minimal 'Sell' suggestions. However, an uptick in 'Hold' ratings implies growing caution amidst possible market challenges. Analysts appear to remain confident, though, with some strategic upgrades noted. Investors should continue to monitor these trends for shifts in market sentiment that could impact future performance and investment strategies.